losartan has been researched along with Genetic Skin Diseases in 2 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, Z | 1 |
| Pei, Y | 1 |
| Tang, X | 1 |
| Rong, L | 1 |
| Chen, L | 1 |
| Jiang, X | 1 |
| Maillet-Lebel, N | 1 |
| Kokta, V | 1 |
| Coulombe, J | 1 |
| Powell, J | 1 |
2 reviews available for losartan and Genetic Skin Diseases
| Article | Year |
|---|---|
Classification and rising medication therapy in stiff skin syndrome: A case report and literature review.
Topics: Child, Preschool; Contracture; Female; Humans; Losartan; Mycophenolic Acid; Skin Diseases, Genetic | 2022 |
A case of segmental stiff skin syndrome treated with systemic losartan.
Topics: Angiotensin II Type 1 Receptor Blockers; Child; Contracture; Diagnosis, Differential; Humans; Losart | 2018 |